Altered splicing and cytoplasmic levels of tRNA synthetases in SF3B1-mutant myelodysplastic syndromes as a therapeutic vulnerability.
Liberante FG, Lappin K, Barros EM, Vohhodina J, Grebien F, Savage KI, Mills KI
Sci Rep. 2019 Feb 25;9(1):2678. doi: 10.1038/s41598-019-39591-7.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
| ID | Plasmid | Purpose |
|---|---|---|
| 113630 | pmKaxxte | to test Cas9 gRNA efficiency or HR-capacity |